Xenon Pharmaceuticals Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2012 | $45.6M | $45.0M | $526.0K | $406.0K |
| FY2013 | $-3.3M | $-3.5M | $156.0K | $575.0K |
| FY2014 | $266.0K | $-1.3M | $1.5M | $760.0K |
| FY2015 | $-18.1M | $-18.7M | $551.0K | $3.7M |
| FY2016 | $-19.6M | $-19.8M | $279.0K | $2.2M |
| FY2017 | $-28.7M | $-29.0M | $315.0K | $2.2M |
| FY2018 | $-34.7M | $-35.2M | $507.0K | $2.6M |
| FY2019 | $-4.7M | $-6.0M | $1.2M | $2.9M |
| FY2020 | $-48.1M | $-50.8M | $2.6M | $5.7M |
| FY2021 | $-69.5M | $-71.6M | $2.1M | $10.0M |
| FY2022 | $-101.0M | $-103.9M | $2.9M | $20.4M |
| FY2023 | $-151.1M | $-156.7M | $5.6M | $32.4M |
| FY2024 | $-181.4M | $-184.5M | $3.1M | $50.7M |
| FY2025 | $-279.1M | $-279.9M | $799.0K | $53.7M |